FDA Inspection 1210944 — Actavis Pharma Development Centre Private Ltd
The FDA completed an inspection of Actavis Pharma Development Centre Private Ltd on July 11, 2023 in Chennai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chennai (India)